ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Petros Pharmaceuticals Inc

Petros Pharmaceuticals Inc (PTPI)

0.0844
-0.0005
(-0.59%)
마감 15 3월 5:00AM
0.0824
-0.002
( -2.37% )
시간외 단일가: 6:20PM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
0.0824
매수가
0.0822
매도가
0.0843
거래량
12,903
0.00 일간 변동폭 0.00
0.0731 52주 범위 1.67
market_cap
전일 종가
0.0844
개장가
-
최근 거래 시간
1
@
0.0823
마지막 거래 시간
18:09:00
재정 규모
-
VWAP
-
평균 볼륨(3m)
7,023,104
발행 주식
10,014,872
배당수익률
-
주가수익률
-0.06
주당순이익(EPS)
-1.38
매출
5.82M
순이익
-13.81M

Petros Pharmaceuticals Inc 정보

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's ope... Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Petros Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker PTPI. The last closing price for Petros Pharmaceuticals was US$0.08. Over the last year, Petros Pharmaceuticals shares have traded in a share price range of US$ 0.0731 to US$ 1.67.

Petros Pharmaceuticals currently has 10,014,872 shares in issue. The market capitalisation of Petros Pharmaceuticals is US$845,255.20 . Petros Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.06.

PTPI 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.0207-20.07759456840.10310.11450.0811133629930.09595929CS
4-0.0776-48.50.160.1620.0731124621320.11125041CS
12-0.2027-71.09786039990.28510.650.073170231040.18644394CS
26-0.2996-78.42931937170.3820.650.073138861510.23874134CS
52-1.4776-94.71794871791.561.670.073121353950.28827007CS
156-10.7176-99.23703703710.828.80.073112610043.11747628CS
260-17.9176-99.54222222221859.5990.0731200888119.38262078CS

PTPI - Frequently Asked Questions (FAQ)

What is the current Petros Pharmaceuticals share price?
The current share price of Petros Pharmaceuticals is US$ 0.0824
How many Petros Pharmaceuticals shares are in issue?
Petros Pharmaceuticals has 10,014,872 shares in issue
What is the market cap of Petros Pharmaceuticals?
The market capitalisation of Petros Pharmaceuticals is USD 845.26k
What is the 1 year trading range for Petros Pharmaceuticals share price?
Petros Pharmaceuticals has traded in the range of US$ 0.0731 to US$ 1.67 during the past year
What is the PE ratio of Petros Pharmaceuticals?
The price to earnings ratio of Petros Pharmaceuticals is -0.06
What is the cash to sales ratio of Petros Pharmaceuticals?
The cash to sales ratio of Petros Pharmaceuticals is 0.14
What is the reporting currency for Petros Pharmaceuticals?
Petros Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Petros Pharmaceuticals?
The latest annual turnover of Petros Pharmaceuticals is USD 5.82M
What is the latest annual profit for Petros Pharmaceuticals?
The latest annual profit of Petros Pharmaceuticals is USD -13.81M
What is the registered address of Petros Pharmaceuticals?
The registered address for Petros Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Petros Pharmaceuticals website address?
The website address for Petros Pharmaceuticals is www.petrospharma.com
Which industry sector does Petros Pharmaceuticals operate in?
Petros Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AFRIForafric Global PLC
US$ 13.85
(59.93%)
100
QVCGBQVC Group Inc
US$ 8.00
(59.36%)
329
LYTLytus Technologies Holdings PTV Ltd
US$ 0.1705
(52.37%)
32.27M
CMCTCreative Media and Community Trust Corporation
US$ 0.4347
(49.54%)
391.33k
PVBCProvident Bancorp Inc
US$ 15.99
(38.80%)
18
LBTYALiberty Global Ltd
US$ 7.17
(-37.71%)
13
ANIKAnika Therapeutics Inc
US$ 11.20
(-29.60%)
9
CSBRChampions Oncology Inc
US$ 7.00
(-24.16%)
25
HBNCHorizon Bancorp Inc
US$ 12.00
(-23.22%)
206
ZDZiff Davis Inc
US$ 31.01
(-22.96%)
14
LYTLytus Technologies Holdings PTV Ltd
US$ 0.1705
(52.37%)
32.27M
ACONAclarion Inc
US$ 0.9592
(24.25%)
6.19M
HEPAHepion Pharmaceuticals Inc
US$ 0.0248
(7.83%)
4.34M
BTOGBit Origin Ltd
US$ 0.3279
(5.77%)
3.17M
QSIQuantum Si Inc
US$ 1.67
(22.79%)
3.03M

PTPI Discussion

게시물 보기
getmoreshares getmoreshares 1 주 전
reverse stock split of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-250 to 1-for-500, with such ratio

At the Special Meeting, we will ask stockholders to: (i) approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock, par value $0.0001 per share (the “Common Stock”) underlying the Series A warrants (the “Series A Warrants”) and Series B warrants (the “Series B Warrants” and, together with the Series A Warrants, the “Series Warrants”) issued by us in a public offering transaction on February 19, 2025 (including shares of Common Stock issuable upon operation of certain anti-dilutions provisions applicable to such Series Warrants, and shares of Common Stock issuable upon “alternative cashless exercise” feature in the Series B Warrants); (ii) approve an amendment to our Amended and Restated Certificate of Incorporation, as amended (the “Charter”), to effect, at the discretion of the Board but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company’s stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined by the board of directors of the Company in its discretion and included in a public announcement; (iii) approve the Third Amendment to the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company’s Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares of Common Stock; (iv) approve an amendment to the Company’s Charter, to increase the number of our authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 shares and to make a corresponding change to the number of authorized shares of capital stock; and (v) approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals.
👍️0
0210 0210 4 주 전
PTPI cool cat...what gives? compared to 29-30 cents 1-week & 1-month VWAP...

https://ih.advfn.com/stock-market/NASDAQ/petros-pharmaceuticals-PTPI/historical
👍️0
0210 0210 4 주 전
PTPI 13-14 cents vs. 24 cents latest public offer, hmmm...
https://www.tipranks.com/news/the-fly/petros-pharmaceuticals-prices-40m-shares-at-24c-in-public-offering?utm_source=edition.cnn.com&utm_medium=referral
👍️0
glenn1919 glenn1919 4 주 전
PTPI...................https://stockcharts.com/h-sc/ui?s=PTPI&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 월 전

 Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. As previously reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission on January 21, 2022, Metuchen Pharmaceuticals LLC (“Metuchen”), a wholly owned subsidiary of Petros Pharmaceuticals, Inc. (the “Company”), entered into that certain (a) Settlement Agreement (the “Settlement Agreement”) and Security Agreement (the “Security Agreement”), each dated January 18, 2022, with Vivus LLC (the “Secured Party”) and (b) Promissory Note dated January 18, 2022, payable to the order of the Secured Party (the “Promissory Note”). As a result of an event of default under the Settlement Agreement and the Security Agreement existing and continuing by virtue of Metuchen’s failure to pay the Installment (as defined in the Promissory Note) that was due October 1, 2024, all the obligations of Metuchen under the Settlement Agreement and the Security Agreement (the “Obligations”) became immediately due and payable on the date of the Foreclosure Notice (as defined below). As of December 10, 2024, the unpaid amount of the Promissory Note was $7,246,634.90 in principal and $237,300.35 in interest. Interest continues to accrue on the foregoing amount at the default rate of 9% per annum. Pursuant to the Security Agreement, the Secured Party holds a security interest against the Collateral (as defined in the Foreclosure Notice). On December 10, 2024, pursuant to a Notice of Proposal to Accept Pledged Collateral in Partial Satisfaction of Indebtedness Pursuant to Uniform Commercial Code Section 9-620 (the “Foreclosure Notice”), the Secured Party proposed to accept all the Collateral (save and except the Specified License Agreement (as defined in the Security Agreement); collectively, the “Foreclosed Collateral”) in partial satisfaction of the Obligations. The Secured Party further proposed in the Foreclosure Notice that its acceptance of the Foreclosed Collateral would only constitute satisfaction of $2,000,000 worth of the Obligations and would not include any other amounts outstanding under the Promissory Note, the Settlement Agreement, or the Security Agreement, including but not limited to (i) all interest accrued or at any time accruing thereon and (ii) all other sums recoverable by the Secured Party from Metuchen by virtue of the Obligations. On December 13, 2024, Metuchen accepted and agreed to the Foreclosure Notice.
👍️0
tw0122 tw0122 3 월 전
Just viagra action .57 + 110% 
👍️0
limer814 limer814 3 월 전
Any news?
👍️0
tw0122 tw0122 3 월 전
.54 + 102% 
👍️0
tw0122 tw0122 3 월 전
Where is everyone running nicely .50 
80% 
👍️0
runncoach runncoach 10 월 전
Read the filings
👍️0
shurtha2000 shurtha2000 10 월 전
Did $15M capital raise 10 months ago so cash should be no problem
👍️ 1
runncoach runncoach 10 월 전
Shocker...and some claimed nearly 2 years cash in the bank lol. Large debt on the books.
👍️0
KeepItRealistic KeepItRealistic 10 월 전
Careful here …
https://stocktwits.com/KeepItRealistic/message/572708730
👍️0
Monksdream Monksdream 11 월 전
PTPI new 52 week low
👍️0
Monksdream Monksdream 11 월 전
PTPI new 52 lo
👍️0
runncoach runncoach 11 월 전
We know what isn't up. Nasty
👍️0
limer814 limer814 11 월 전
What's up
👍️0
runncoach runncoach 11 월 전
Exactly
👍️0
KeepItRealistic KeepItRealistic 11 월 전
New lows = new low conversion rates
👍️0
runncoach runncoach 11 월 전
Likely nearing 8 million shares since another installment payment was due this week. Lost nearly 14 million dollars on less than 6 million in sales. Sales last year were lower than 2022. Patent expiring in 12 months. Lot's of other fun nuggets that most won't bother to read.
This one spells out further dilution it would seem:
Going Concern

Petros has experienced net losses and negative cash flows from operations since our inception. As of December 31, 2023, the Company had cash of approximately $13.3 million, positive working capital of $9.6 million, an accumulated deficit of approximately $98.9 million and used cash in operations during the twelve months ended December 31, 2023, of approximately $7.6 million. The Company does not currently have sufficient available liquidity to fund its operations for at least the next 12 months. These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.

GLTA
👍️0
KeepItRealistic KeepItRealistic 11 월 전
$PTPI 10k filed

https://www.otcmarkets.com/filing/html?id=17418536&guid=11Q-knncHeK-B3h

“As of March 26, 2024, the registrant had 6,875,814 shares of common stock outstanding.”
👍️0
Monksdream Monksdream 12 월 전
PTPI under $2
👍️0
Jess070283 Jess070283 12 월 전
FDA meeting tomorrow. Definitely swinging some shares for that IMO.
👍️ 1 ♥️ 1
wamuer wamuer 12 월 전
lots of pre market volume, looking good
👍️0
wamuer wamuer 12 월 전
https://www.sec.gov/Archives/edgar/data/1815903/000110465924037906/tm249589d1_8k.htm
👍️0
bman22 bman22 12 월 전
I'm in @ 485 shares. Let's go!
👍️ 1
wamuer wamuer 12 월 전
https://www.accesswire.com/844279/petros-pharmaceuticals-successfully-launches-ai-tool-in-collaboration-with-multi-billion-dollar-software-provider
👍️ 1
wamuer wamuer 12 월 전
there it is :))
👍️ 1
limer814 limer814 12 월 전
Come on ,let's get back in to the1.60s
👍️ 1
limer814 limer814 12 월 전
Well that's alot of premarket volume
👍️ 1
Backstabbed Backstabbed 1 년 전
Nice comeback
👍️ 1
wamuer wamuer 1 년 전
finally been held for so long
👍️ 1
limer814 limer814 1 년 전
Something is up
👍️ 1
wamuer wamuer 1 년 전
great ending
at its high :)))
👍️0
limer814 limer814 1 년 전
Nice close 1.66
👍️0
Backstabbed Backstabbed 1 년 전
$PTPI - love it
👍️ 1
limer814 limer814 1 년 전
Getting perky
👍️0
Backstabbed Backstabbed 1 년 전
Nice
👍️0
limer814 limer814 1 년 전
Well good morning $PTPI
👍️0
Backstabbed Backstabbed 1 년 전
Yup! Moon mentioned it again yesterday
👍️0
limer814 limer814 1 년 전
$PTPI These Bios are quiet until they are not. While you wait, you can watch this recent YouTube video with the Ceo. He has quite the experience with what he did in prior companies.https://t.co/80hPCoNPPk— Keith Rah (@keith_rah) March 6, 2024
👍️0
limer814 limer814 1 년 전
BTC is at it again this am
👍️0
KeepItRealistic KeepItRealistic 1 년 전
Avg volume (3m) is 907,606

So todays volume is inline with the average
👍️0
Backstabbed Backstabbed 1 년 전
Is it just me? Or all liquidity went towards Crypto and Bitcoin
👍️0
limer814 limer814 1 년 전
Added down here in the low 1.50s
👍️0
limer814 limer814 1 년 전
I'm keep an eye for the news symbol on the app
👍️0
KeepItRealistic KeepItRealistic 1 년 전
Volume down today
👍️0
runncoach runncoach 1 년 전
No worries
👍️0
KeepItRealistic KeepItRealistic 1 년 전
Yep
Your calculations were spot on !
Sorry for being in denial lol
👍️0
runncoach runncoach 1 년 전
Now you see why I was approximating a million shares per month for these past 5 months. 8 more months to go
👍️0

최근 히스토리

Delayed Upgrade Clock